C-Reactive Protein and Brain Natriuretic Peptides Harmonization

• Published in: Clinica chimica acta Vol. 562; p. 119848
• Main Authors: Pasqualetti, Sara, Mussap, Michele, Monteverde, Elena, Sortino, Morena, Locatelli, Massimo, Finazzi, Sergio, Tomaiuolo, Rossella, Banfi, Giuseppe, Carobene, Anna
• Format: Journal Article
• Language: English
• Published: Netherlands Elsevier B.V 15.08.2024
• Subjects: analytical phase; Biomarkers - blood; C-Reactive Protein - analysis; Cardiovascular Diseases - blood; Cardiovascular Diseases - diagnosis; CRP; harmonisation; Humans; Natriuretic Peptide, Brain - analysis; Natriuretic Peptide, Brain - blood; NT-proBNP; Peptide Fragments - analysis; Peptide Fragments - blood; post-analytical phase; pre-analytical phase; standardisation; CRP; VTE; HFpEF; COVID-19; AECOPD; NT-proBNP; MEIA; harmonisation; suPAR; STEMI; KD; AMI; hs-CRP; CLIA; eGFR; FIRS; analytical phase; CAD; LUS; SMD; VA; post-analytical phase; EDTA; ECLIA; CVD; pre-analytical phase; ACS; standardisation; PE; PCI; CHD; HF; AHF; COPD; ELISA
• ISSN: 0009-8981; 1873-3492; 1873-3492
• DOI: 10.1016/j.cca.2024.119848

•Identified measurement variability in CRP and NT-proBNP.•Highlighted gaps in standardization protocols.•Urged for robust international guidelines.•Advocated for standardized collection protocols. The harmonization of laboratory biomarkers is pivotal in ensuring consistent and reliable diagnostic outcomes across different clinical settings. This systematic review examines the harmonization of C-Reactive Protein (CRP) and N-Terminal Prohormone of Brain Natriuretic Peptide (NT-proBNP) measurements, both of which are jointly utilized in the diagnosis and management of cardiovascular diseases. To identify relevant studies, we searched the PubMed electronic database using specific medical subject headings and keywords such as C-Reactive Protein, CRP, high sensitivity C-Reactive Protein (hs-CRP), N-terminal pro B-type natriuretic peptide, and NT-proBNP, focusing on publications from June 1 to September 26, 2021. The query filtered studies to include only those in English involving human subjects. From our search, 97 articles met the inclusion criteria and were included for in-depth analysis. Despite their widespread use, significant variability remains in the measurements of CRP and NT-proBNP due to a lack of standardized pre-analytical, analytical, and post-analytical practices. This review highlights the consequences of this variability on clinical decision-making and patient outcomes and emphasizes the need for international standards and guidelines to achieve better harmonization. Our findings advocate for the establishment of universal protocols to enhance the reliability of these biomarker measurements across different clinical environments, ensuring improved healthcare delivery.